Pierre Jean Guillausseau

Summary

Country: France

Publications

  1. ncbi request reprint [Compliance and optimisation of oral antidiabetic therapy. A longitudinal study]
    Pierre Jean Guillausseau
    Service de Medecine B, Hopital Lariboisiere, 2 rue Ambroise Pare, 75010 Paris Université Paris 7
    Presse Med 33:156-60. 2004
  2. ncbi request reprint Impact of compliance with oral antihyperglycemic agents on health outcomes in type 2 diabetes mellitus: a focus on frequency of administration
    Pierre Jean Guillausseau
    Department of Medicine B, Lariboisiere Hospital, University Paris 7 Denis Diderot, Paris, France
    Treat Endocrinol 4:167-75. 2005
  3. ncbi request reprint Maternally inherited diabetes and deafness: a multicenter study
    P J Guillausseau
    Department of Medicine B, Lariboisiere Hospital, 2 rue Ambroise Pare, F75010 Paris, University Paris 7 Denis Diderot, France
    Ann Intern Med 134:721-8. 2001
  4. ncbi request reprint [Compliance to treatment and type 2 diabetes: impact on glycemic balance]
    Pierre Jean Guillausseau
    Presse Med 32:70. 2003
  5. ncbi request reprint [Urinary tract infections and diabetes mellitus]
    Pierre Jean Guillausseau
    Service de Medecine B, Hopital Lariboisiere, 75475 Paris
    Rev Prat 53:1790-6. 2003
  6. ncbi request reprint [Pathogenesis of type 2 diabetes mellitus]
    P J Guillausseau
    Service de médecine interne B, Hopital Lariboisiere, 2, rue Ambroise Pare, 75475 Paris 10, France
    Rev Med Interne 24:730-7. 2003
  7. ncbi request reprint [Type II diabetes in children and adults]
    Pierre Jean Guillausseau
    Service de Medecine B, hôpital Lariboisière et faculté de médecine Lariboisière Saint Louis, Universite Paris 7 Denis Diderot, 75475 Paris
    Rev Prat 53:1463-71. 2003
  8. ncbi request reprint Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice
    P J Guillausseau
    Service de Medecine B, Hopital Lariboisiere, Paris et Université Paris 7 Denis Diderot, France
    Diabetes Metab 29:79-81. 2003
  9. ncbi request reprint 24-hour glycemic profile in type 2 diabetic patients treated with gliclazide modified release once daily
    P J Guillausseau
    Service de Medecine B, Hopital Lariboisiere, 2 rue Ambroise Pare, 75010 Paris, France
    Diabetes Metab 27:133-7. 2001
  10. ncbi request reprint Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance
    Franck Mauvais-Jarvis
    Department of Endocrinology and Diabetes, Saint Louis Hospital and University of Paris VII School of Medicine, Paris, France
    Diabetes 53:645-53. 2004

Detail Information

Publications18

  1. ncbi request reprint [Compliance and optimisation of oral antidiabetic therapy. A longitudinal study]
    Pierre Jean Guillausseau
    Service de Medecine B, Hopital Lariboisiere, 2 rue Ambroise Pare, 75010 Paris Université Paris 7
    Presse Med 33:156-60. 2004
    ..5 to 56.8%, and increase in percentage of once-daily dosing regimen from 12 to 58.4%...
  2. ncbi request reprint Impact of compliance with oral antihyperglycemic agents on health outcomes in type 2 diabetes mellitus: a focus on frequency of administration
    Pierre Jean Guillausseau
    Department of Medicine B, Lariboisiere Hospital, University Paris 7 Denis Diderot, Paris, France
    Treat Endocrinol 4:167-75. 2005
    ..Therefore, optimization of treatment through a reduction in the frequency of antihyperglycemic administration could be a valuable weapon in the battle to improve health outcomes and reduce the burden of type 2 diabetes...
  3. ncbi request reprint Maternally inherited diabetes and deafness: a multicenter study
    P J Guillausseau
    Department of Medicine B, Lariboisiere Hospital, 2 rue Ambroise Pare, F75010 Paris, University Paris 7 Denis Diderot, France
    Ann Intern Med 134:721-8. 2001
    ..Maternally inherited diabetes and deafness (MIDD), which is seen in 0.5% to 2.8% of patients with type 2 diabetes mellitus, is related to a point mutation at position 3243 of mitochondrial (mt) DNA. Its clinical description is incomplete...
  4. ncbi request reprint [Compliance to treatment and type 2 diabetes: impact on glycemic balance]
    Pierre Jean Guillausseau
    Presse Med 32:70. 2003
  5. ncbi request reprint [Urinary tract infections and diabetes mellitus]
    Pierre Jean Guillausseau
    Service de Medecine B, Hopital Lariboisiere, 75475 Paris
    Rev Prat 53:1790-6. 2003
    ..Nosocomial UTI is frequent in such patients. Meticulous preventive measures are the best means of reducing the prevalence of UTI in diabetics...
  6. ncbi request reprint [Pathogenesis of type 2 diabetes mellitus]
    P J Guillausseau
    Service de médecine interne B, Hopital Lariboisiere, 2, rue Ambroise Pare, 75475 Paris 10, France
    Rev Med Interne 24:730-7. 2003
    ..It results from aging of the population and from "western" lifestyle, with progressive increase in mean body weight, due to excess in energy intake, decreased energy expenses and low physical activity level...
  7. ncbi request reprint [Type II diabetes in children and adults]
    Pierre Jean Guillausseau
    Service de Medecine B, hôpital Lariboisière et faculté de médecine Lariboisière Saint Louis, Universite Paris 7 Denis Diderot, 75475 Paris
    Rev Prat 53:1463-71. 2003
  8. ncbi request reprint Influence of oral antidiabetic drugs compliance on metabolic control in type 2 diabetes. A survey in general practice
    P J Guillausseau
    Service de Medecine B, Hopital Lariboisiere, Paris et Université Paris 7 Denis Diderot, France
    Diabetes Metab 29:79-81. 2003
    ..To address compliance with oral antidiabetic agents and its impact on metabolic control in type 2 diabetic patients treated in general practice...
  9. ncbi request reprint 24-hour glycemic profile in type 2 diabetic patients treated with gliclazide modified release once daily
    P J Guillausseau
    Service de Medecine B, Hopital Lariboisiere, 2 rue Ambroise Pare, 75010 Paris, France
    Diabetes Metab 27:133-7. 2001
    ..The present study was undertaken to assess the effect of a new formulation of gliclazide administered once daily, gliclazide modified release, on plasma glucose levels over 24 hours...
  10. ncbi request reprint Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance
    Franck Mauvais-Jarvis
    Department of Endocrinology and Diabetes, Saint Louis Hospital and University of Paris VII School of Medicine, Paris, France
    Diabetes 53:645-53. 2004
    ....
  11. ncbi request reprint [Drug treatment of type 2 diabetes]
    Amélie Tielmans
    Service de médecine interne B, AP HP, Hopital Lariboisiere, 75010 Paris, France
    Presse Med 36:269-78. 2007
    ..GLP-1 (Glucagon-Like Peptide-1) analogs and DPP-IV (dipeptidyl-peptidase-IV) inhibitors are new drug classes currently under development...
  12. ncbi request reprint [Drug treatment in type 2 diabetes (part 2)]
    Amélie Tielmans
    Service de médecine interne B, AP HP, Hopital Lariboisiere, Paris
    Presse Med 36:467-74. 2007
    ..5%. New guidelines for management of type 2 diabetes were published in 2006...
  13. doi request reprint Evaluation of retinal function and flicker light-induced retinal vascular response in normotensive patients with diabetes without retinopathy
    Amelie Lecleire-Collet
    Departments of Ophthalmology, Hopital Fernand Widal, Assistance Publique Hopitaux de Paris, Paris 7 University, Paris, France
    Invest Ophthalmol Vis Sci 52:2861-7. 2011
    ..To correlate retinal function with vascular response to flicker light in normotensive patients with diabetes without diabetic retinopathy (DR)...
  14. ncbi request reprint A possible hypophosphatemia-induced, life-threatening encephalopathy in diabetic ketoacidosis: a case report
    Bruno Megarbane
    Medical Critical Care Department, Lariboisiere Hospital, Paris, France
    Am J Med Sci 333:384-6. 2007
    ..Our data strongly suggest that phosphate depletion-induced encephalopathy probably originates from direct impairment of cerebral electrophysiological activity rather than from cardiac flow alteration...
  15. doi request reprint Immunocytochemistry with cytokeratin 19 and anti-human mesothelial cell antibody (HBME1) increases the diagnostic accuracy of thyroid fine-needle aspirations: preliminary report of 150 liquid-based fine-needle aspirations with histological control
    Beatrix Cochand-Priollet
    Department of Pathology and Cytopathology, Lariboisiere Hospital, Paris, France
    Thyroid 21:1067-73. 2011
    ..We aimed to assess the diagnostic accuracy of immunocytochemistry (ICC) of thyroid FNA to improve its sensitivity and specificity...
  16. doi request reprint Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials
    Nish Chaturvedi
    International Centre for Circulatory Health, National Heart and Lung Institute, Imperial College Healthcare NHS Trust, London, UK
    Lancet 372:1394-402. 2008
    ..We therefore designed the DIabetic REtinopathy Candesartan Trials (DIRECT) Programme to assess whether candesartan could reduce the incidence and progression of retinopathy in type 1 diabetes...
  17. doi request reprint Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial
    Anne Katrin Sjølie
    Department of Ophthalmology, Odense University Hospital, Odense, Denmark
    Lancet 372:1385-93. 2008
    ..Diabetic retinopathy remains a leading cause of visual loss in people of working age. We examined whether candesartan treatment could slow the progression and, secondly, induce regression of retinopathy in people with type 2 diabetes...
  18. ncbi request reprint PROactive study
    Pierre Jean Guillausseau
    Lancet 367:23; author reply 26-7. 2006